Log in to save to my catalogue

Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatmen...

Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatmen...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_684885a7537f4236b7240fae1b7723c2

Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury

About this item

Full title

Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2025-02, Vol.23 (1), p.98-17

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Spinal cord injury (SCI), characterized by the disruption of neural pathways and an increase in inflammatory cell infiltration, leads to profound and lasting neurological deficits, with a high risk of resulting in permanent disability. Currently, the therapeutic landscape for SCI is notably sparse, with limited effective treatment options available...

Alternative Titles

Full title

Methylprednisolone substituted lipid nanoparticles deliver C3 transferase mRNA for combined treatment of spinal cord injury

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_684885a7537f4236b7240fae1b7723c2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_684885a7537f4236b7240fae1b7723c2

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-025-03153-z

How to access this item